October is always a key month. Here are some of the highlights that we shared these last weeks: 🌐 The launch of our website in Spanish and French! 🩷 Breast Cancer Awareness Month: the MASAI trial has recently proven that AI can cut radiologists' workload by 44% 💡 QP-Prostate helps radiologists detect over 90% of prostate cancer cases in Spain Stay up to date on #AI, #Radiomics, and #CancerCare in our newsletter - subscribe now!
Many of you have asked how to help the victims of the severe storms and flooding these days in Valencia. Here’s a list of organizations and associations actively providing assistance on the ground:
Next November 13, we will be at the annual Personalized Medicine Coalition conference in Boston, and our CEO, Dr. Ángel Alberich-Bayarri will participate in the session "Transforming Standard-of-Care Imaging into Precision Diagnostics" together with Chiranjiv Singh, Okan Ekinci, MD MBA and Megan Nacar. If you’re around, swing by Room 217 at 12:30 PM and join us for an engaging debate. We’d love to see you there! Check out the full program at https://lnkd.in/dzB6E7mM
Our heartfelt support goes out to all those affected by the heavy rains and flash floods in the Valencian Community, home to Quibim. Todo nuestro apoyo a los afectados y las víctimas de la DANA en su paso por la Comunidad Valenciana, nuestra casa.
🇨🇵 Et nous voilà aussi plus proches des professionnels de santé en France grâce au lancement de notre site web entièrement en français. Rendez-nous visite sur www.quibim.com/fr pour découvrir Quibim et réserver une démo en français!
¡Ya estamos en vivo! Desde hoy la web de Quibim también en español 🌎 https://quibim.com/es/ Nos enorgullece enormemente compartir el lanzamiento de nuestra página web en el idioma de millones de profesionales de la salud en todo el mundo. Visítanos y descubre Quibim en español. ¡Bienvenidos!
Shortly after a month of attending #ESMO24, we are back in Barcelona for the 36th edition of EORTC - European Organisation for Research and Treatment of Cancer, National Cancer Institute (NCI), and American Association for Cancer Research (ENA 2024) Symposium ⭐ A unique occasion to get ahold of the latest scientific advancements in precision medicine, drug development, and cancer care. #PrecisionMedicine #CancerCare #healthcareInnovation
Yesterday we played at home!📍 We had the privilege of participating in the 7th edition of VDS, contributing to two insightful roundtables: “It's Happening Now: Real-World Examples Showcasing the Healthcare Transformation”, with our CEO, Dr. Ángel Alberich-Bayarri, and “AI Revolution: Shaping Supply Chain and Entertainment. Insights into Technological and Investment Strategies” with Quibim's VP of AI, Ana Jimenez Pastor. A big thank you to everyone who joined us in these discussions, and to the event organizers for inviting Quibim for another year. #VDS continues to be an exceptional platform to gather new insights, discuss current and future ideas, and connect with leading professionals. #PrecisionMedicine #AIInHealthcare #VDS24
Today, our Clinical Project Manager Alejandra Estepa Fernández, PhD, presented at the European Association of Nuclear Medicine (EANM) 2024 our poster "Imaging Features and Clinical Data-Based Network Analysis of CAR-T Treated B-Cell Lymphoma Patients in Relation to Their TP53 Mutation Status", where the use of QP-Insights was key. Check out her post to know more!
Last year alone, nearly 30,000 cases of #ProstateCancer were diagnosed in Spain. Despite the gravity of this issue, the 5-year survival rate for patients diagnosed with advanced-stage disease (stage IV) remains alarmingly low at just 28%, highlighting the limitations of current population screening programs. In light of this, Dr. Eliseo Vañó Galván emphasizes the critical role of AI-driven solutions like QP-Prostate, which are already showing promising results in Spanish hospitals. These tools are becoming essential for more effective prostate cancer management.
